IFF has announced that Andreas Fibig, IFF’s chairman and chief executive officer, will retire after a 10-year tenure and more than seven years as IFF’s chairman and CEO.
The Board of Directors is evaluating candidates to succeed Fibig, and he looks forward to continuing in his role until a successor is named, expected by early 2022, after which he will stay for a period of time to support a seamless transition. At the time of his retirement, Fibig will also step down from IFF’s Board of Directors.
Ed Breen, lead independent director of IFF, said, “Over the past several years, Andreas has successfully led IFF through some of the most significant milestones in the company’s history. IFF has benefited from his experience and commitment to transformation that redefines the possibilities for our industry. Our future is bright as IFF is well-positioned to drive long-term value creation for all stakeholders. The board and I are grateful for everything Andreas has helped IFF accomplish. We wish him all the best and appreciate his ongoing leadership to ensure a smooth transition as we search for his successor.”
Andreas Fibig, chairman and CEO, said, “Leading this 132-year-old iconic company through a true transformation this past decade has been an honor. With the company delivering strong sales growth and the integration of Nutrition & Biosciences well underway, I feel now is the right time to let the next chapter of IFF’s legacy begin. We have created an unrivaled platform that is a true innovation partner to our customers and instilled a real purpose within our company to become a global leader in sustainability. Of all we have accomplished at IFF, what I am most proud of is that IFF has returned to its rightful place as the clear leader in our field, extending its illustrious legacy and poised to define the evolution of our industry for years to come. IFF has never been in a better position, and I look forward to watching its next chapter unfold.”